Cortexyme is starting a phase II trial for their drug COR388 soon which is a targeted anti-microbial for a specific organism which they have identified as Alzhe

Cortexyme is starting a phase II trial for their drug COR388 soon which is a targeted anti-microbial for a specific organism which they have identified as Alzheimer's related and believe is the cause of Alzheimers. They should have some results in the next year or so. See here for more info. https://www.cortexyme.com/news https://www.cortexyme.com/news